{"id":"https://openalex.org/W1998244456","doi":"https://doi.org/10.1089/scd.2011.0405","title":"The i Blood Group Antigen as a Marker for Umbilical Cord Blood-Derived Mesenchymal Stem Cells","display_name":"The i Blood Group Antigen as a Marker for Umbilical Cord Blood-Derived Mesenchymal Stem Cells","publication_year":2011,"publication_date":"2011-09-20","ids":{"openalex":"https://openalex.org/W1998244456","doi":"https://doi.org/10.1089/scd.2011.0405","mag":"1998244456","pmid":"https://pubmed.ncbi.nlm.nih.gov/21933024"},"language":"en","primary_location":{"id":"doi:10.1089/scd.2011.0405","doi":"https://doi.org/10.1089/scd.2011.0405","is_oa":false,"landing_page_url":"https://doi.org/10.1089/scd.2011.0405","pdf_url":null,"source":{"id":"https://openalex.org/S120158623","display_name":"Stem Cells and Development","issn_l":"1525-8165","issn":["1525-8165","1547-3287","1557-8534","2168-6580"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stem Cells and Development","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109928423","display_name":"Tia Hirvonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tia Hirvonen","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084523985","display_name":"Heli Suila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Heli Suila","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058664830","display_name":"Annika Kotovuori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Annika Kotovuori","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051557289","display_name":"Ilja Ritamo","orcid":"https://orcid.org/0000-0002-7655-884X","observed_orcids":["https://orcid.org/0000-0002-7655-884X"]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Ilja Ritamo","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045906739","display_name":"Annamari Heiskanen","orcid":"https://orcid.org/0009-0009-7867-4156","observed_orcids":["https://orcid.org/0009-0009-7867-4156"]},"institutions":[{"id":"https://openalex.org/I4210137445","display_name":"Glykos (Finland)","ror":"https://ror.org/04nmcca26","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210137445"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Annamari Heiskanen","raw_affiliation_strings":["Glykos Finland Ltd","Glykos Finland Ltd., Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glykos Finland Ltd","institution_ids":["https://openalex.org/I4210137445"]},{"raw_affiliation_string":"Glykos Finland Ltd., Helsinki, Finland","institution_ids":["https://openalex.org/I4210137445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109986383","display_name":"Pertti Sistonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Pertti Sistonen","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085798641","display_name":"Heidi Anderson","orcid":"https://orcid.org/0000-0002-5561-0901","observed_orcids":["https://orcid.org/0000-0002-5561-0901"]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Heidi Anderson","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030158598","display_name":"Tero Satomaa","orcid":"https://orcid.org/0000-0001-8547-2661","observed_orcids":["https://orcid.org/0000-0001-8547-2661"]},"institutions":[{"id":"https://openalex.org/I4210137445","display_name":"Glykos (Finland)","ror":"https://ror.org/04nmcca26","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210137445"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tero Satomaa","raw_affiliation_strings":["Glykos Finland Ltd","Glykos Finland Ltd., Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glykos Finland Ltd","institution_ids":["https://openalex.org/I4210137445"]},{"raw_affiliation_string":"Glykos Finland Ltd., Helsinki, Finland","institution_ids":["https://openalex.org/I4210137445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103247623","display_name":"Juhani Saarinen","orcid":"https://orcid.org/0009-0002-1782-6100","observed_orcids":["https://orcid.org/0009-0002-1782-6100"]},"institutions":[{"id":"https://openalex.org/I4210137445","display_name":"Glykos (Finland)","ror":"https://ror.org/04nmcca26","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210137445"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Juhani Saarinen","raw_affiliation_strings":["Glykos Finland Ltd","Glykos Finland Ltd., Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glykos Finland Ltd","institution_ids":["https://openalex.org/I4210137445"]},{"raw_affiliation_string":"Glykos Finland Ltd., Helsinki, Finland","institution_ids":["https://openalex.org/I4210137445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029126793","display_name":"Sari L. Tiitinen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Sari Tiitinen","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083532862","display_name":"Jarkko R\u00e4bin\u00e4","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jarkko R\u00e4bin\u00e4","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054141328","display_name":"Saara Laitinen","orcid":"https://orcid.org/0000-0002-3482-1304","observed_orcids":["https://orcid.org/0000-0002-3482-1304"]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Saara Laitinen","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072958596","display_name":"Suvi Natunen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Suvi Natunen","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062841765","display_name":"Leena Valmu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801434414","display_name":"Finnish Red Cross","ror":"https://ror.org/045thge14","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I2801434414"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Leena Valmu","raw_affiliation_strings":["Finnish Red Cross Blood Service","Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finnish Red Cross Blood Service","institution_ids":["https://openalex.org/I2801434414"]},{"raw_affiliation_string":"Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland","institution_ids":["https://openalex.org/I2801434414"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062841765"],"corresponding_institution_ids":["https://openalex.org/I2801434414"],"apc_list":null,"apc_paid":null,"fwci":0.839,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.67038533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"21","issue":"3","first_page":"455","last_page":"464"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.6366999745368958,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.6366999745368958,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.32589998841285706,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/umbilical-cord-mesenchymal-stem-cells","display_name":"human umbilical cord mesenchymal stem cells","score":0.9419999718666077},{"id":"https://openalex.org/keywords/poly-n-acetyllactosamine","display_name":"poly-N-acetyllactosamine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/galectin-3","display_name":"galectin-3","score":0.8659999966621399},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6629999876022339},{"id":"https://openalex.org/keywords/stem-cell-differentiation","display_name":"stem cell differentiation","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7745950222015381},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.7712147831916809},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6607592105865479},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5913796424865723},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5637943148612976},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47562530636787415},{"id":"https://openalex.org/C40722700","wikidata":"https://www.wikidata.org/wiki/Q1103544","display_name":"Cluster of differentiation","level":3,"score":0.46760573983192444},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4544456899166107},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.454174280166626},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.45077961683273315},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3350951671600342},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10296228528022766}],"mesh":[{"descriptor_ui":"D000606","descriptor_name":"Amino Sugars","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005312","descriptor_name":"Fetal Blood","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D005312","descriptor_name":"Fetal Blood","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007048","descriptor_name":"I Blood-Group System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D017351","descriptor_name":"N-Acetylglucosaminyltransferases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D037502","descriptor_name":"Galectin 3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D037502","descriptor_name":"Galectin 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055153","descriptor_name":"Stem Cell Niche","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/scd.2011.0405","doi":"https://doi.org/10.1089/scd.2011.0405","is_oa":false,"landing_page_url":"https://doi.org/10.1089/scd.2011.0405","pdf_url":null,"source":{"id":"https://openalex.org/S120158623","display_name":"Stem Cells and Development","issn_l":"1525-8165","issn":["1525-8165","1547-3287","1557-8534","2168-6580"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stem Cells and Development","raw_type":"journal-article"},{"id":"pmid:21933024","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21933024","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stem cells and development","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321855","display_name":"Tekes","ror":"https://ror.org/02ag8cq23"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W70260800","https://openalex.org/W649532618","https://openalex.org/W1492512703","https://openalex.org/W1505476546","https://openalex.org/W1515496124","https://openalex.org/W1562003034","https://openalex.org/W1565074995","https://openalex.org/W1567337175","https://openalex.org/W1594682500","https://openalex.org/W1595638561","https://openalex.org/W1777997745","https://openalex.org/W1953804216","https://openalex.org/W1964785938","https://openalex.org/W1965953554","https://openalex.org/W1967033957","https://openalex.org/W1969724065","https://openalex.org/W1970290833","https://openalex.org/W1972042205","https://openalex.org/W1972416794","https://openalex.org/W1976484683","https://openalex.org/W1980390032","https://openalex.org/W1998462395","https://openalex.org/W2013209387","https://openalex.org/W2014868460","https://openalex.org/W2016027337","https://openalex.org/W2021371517","https://openalex.org/W2025371271","https://openalex.org/W2029591783","https://openalex.org/W2036348189","https://openalex.org/W2038963578","https://openalex.org/W2039446688","https://openalex.org/W2040365072","https://openalex.org/W2049405885","https://openalex.org/W2053733320","https://openalex.org/W2059379158","https://openalex.org/W2066747865","https://openalex.org/W2067074405","https://openalex.org/W2084868093","https://openalex.org/W2088373848","https://openalex.org/W2089974771","https://openalex.org/W2099205356","https://openalex.org/W2104225093","https://openalex.org/W2116806859","https://openalex.org/W2122403086","https://openalex.org/W2123675565","https://openalex.org/W2129665916","https://openalex.org/W2135827569","https://openalex.org/W2143168188","https://openalex.org/W2148657684","https://openalex.org/W2156416604","https://openalex.org/W2156613209","https://openalex.org/W2159724909","https://openalex.org/W2161994928","https://openalex.org/W2162699339","https://openalex.org/W2164182106","https://openalex.org/W4211208250"],"related_works":["https://openalex.org/W2105279389","https://openalex.org/W1594835705","https://openalex.org/W2049807963","https://openalex.org/W2138621885","https://openalex.org/W6920854952","https://openalex.org/W2610999391","https://openalex.org/W2399108134","https://openalex.org/W2159724909","https://openalex.org/W2782741780","https://openalex.org/W2390675853"],"abstract_inverted_index":{"Multipotent":[0],"mesenchymal":[1],"stem":[2],"cells":[3,134],"(MSCs)":[4],"offer":[5],"great":[6],"promise":[7],"for":[8,34,63,172,208],"future":[9],"regenerative":[10],"and":[11,23,27,55,65,81,115,120],"anti-inflammatory":[12],"therapies.":[13],"However,":[14],"there":[15],"is":[16,161,169],"a":[17,170,229],"lack":[18],"of":[19,53,76,96,157,176,185,239],"methods":[20],"to":[21,39,191],"quickly":[22],"efficiently":[24],"isolate,":[25],"characterize,":[26],"ex":[28],"vivo":[29],"expand":[30],"desired":[31],"cell":[32,41,68,83,93,182],"populations":[33,42],"therapeutic":[35],"purposes.":[36],"Single":[37],"markers":[38],"identify":[40],"have":[43,87],"not":[44,132],"been":[45,189],"characterized;":[46],"instead,":[47],"all":[48],"characterizations":[49],"rely":[50],"on":[51,73,217],"panels":[52],"functional":[54],"phenotypical":[56],"properties.":[57],"Glycan":[58],"epitopes":[59],"can":[60],"be":[61,226],"used":[62,112,227],"identifying":[64],"isolating":[66],"specific":[67,79,155],"types":[69],"from":[70,136],"heterogeneous":[71],"populations,":[72],"the":[74,92,97,141,153,158,173,193,213],"basis":[75],"their":[77],"cell-type":[78],"expression":[80,95,149,156,184],"prominent":[82],"surface":[84,94,183],"localization.":[85],"We":[86,111,138,179],"now":[88],"studied":[89],"in":[90,105,128,133,212],"detail":[91],"blood":[98,108],"group":[99],"i":[100,159,167,200],"epitope":[101],"(linear":[102],"poly-N-acetyllactosamine":[103,124,224],"chain)":[104],"umbilical":[106],"cord":[107],"(UCB)-derived":[109],"MSCs.":[110,198],"flow":[113],"cytometry":[114],"mass":[116,144],"spectrometric":[117,145],"glycan":[118,146],"analysis":[119,150],"discovered":[121],"that":[122,152,222],"linear":[123,223],"structures":[125],"are":[126],"expressed":[127],"UCB-derived":[129],"MSCs,":[130],"but":[131],"differentiated":[135],"them.":[137],"further":[139],"verified":[140],"findings":[142],"by":[143,163,197],"analysis.":[147],"Gene":[148],"indicated":[151],"stem-cell":[154],"antigen":[160,168,201],"determined":[162],"\u03b23-N-acetylglucosaminyltransferase":[164],"5.":[165],"The":[166,199],"ligand":[171,207],"galectin":[174],"family":[175],"soluble":[177],"lectins.":[178],"found":[180],"concomitant":[181],"galectin-3,":[186],"which":[187],"has":[188],"reported":[190],"mediate":[192],"immunosuppressive":[194,210],"effects":[195],"exerted":[196],"may":[202],"serve":[203],"as":[204,228],"an":[205,237],"endogenous":[206],"this":[209],"agent":[211],"MSC":[214,240],"microenvironment.":[215],"Based":[216],"these":[218],"findings,":[219],"we":[220],"suggest":[221],"could":[225],"novel":[230],"UCB-MSC":[231],"marker":[232],"either":[233],"alone":[234],"or":[235],"within":[236],"array":[238],"markers.":[241]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}